STIM2 and neoplasm: In addition, loss of STIM2 affected the ability of T cells to maintain NFAT concentrations in the nucleus, implicating that even STIM2 mutations could potentially impact transcriptional processes in cytotoxic T cells that are important for their activity against tumour cells (Oh-Hora et al, 2008).